Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis

Hurst, N P; Ruta, Danny; Kind, Paul

doi:10.1093/rheumatology/37.8.862

Cited by 186 publications

(133 citation statements)

References 3 publications

Supporting

Mentioning

115

Contrasting

Unclassified

Order By: Relevance

“…At each visit, a 28-joint count of the tender (TJC) and swollen (SJC) joints, the erythrocyte sedimentation rate (ESR; Westergren method), and results from a 100-mm linear general health scale (GH) were recorded. In addition, at weeks 6 and 22 (randomization and final assessment, respectively), the modified Health Assessment Questionnaire (13), the Short-Form 12 (SF-12) version of the Medical Outcomes Study (14), a visual analog scale for physician assessment of disease activity (100 mm), and a visual analog scale for patient assessment of pain (100 mm) were completed.…”

Section: Methodsmentioning

confidence: 99%

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial

Lambert¹,

Sandhu²,

Lochhead³

et al. 2004

Arthritis & Rheumatism

View full text Add to dashboard Cite

Results. Sixty-four patients were eligible for entry and were switched from oral MTX to 15 mg/week IM MTX. At baseline, the mean ؎ SD DAS28 was 5.6 ؎ 0.88; after 6 weeks of IM MTX, the DAS28 had improved by a mean of 0.42 (95% confidence interval [95% CI] 0.15-0.69). At 6 weeks, 54 patients still had a DAS28 of >3.2 and were therefore eligible for randomization. By 22 weeks, 1 patient (3.7%) in each group achieved the primary outcome of a DAS28 <3.2 (95% CI for the difference between the groups ؊15% to ؉15%). Five patients (18.5%) in each group showed an improvement of >1.2 in the DAS28 (95% CI for the difference between the groups ؊18% to ؉18%). One patient (3.7%) in each group achieved an ACR20 response, but none achieved a good response as defined by the EULAR response criteria. One patient in each group had a serious adverse reaction; minor adverse reactions were more frequently reported in the dose escalation group.Conclusion. Switching from oral to parenteral MTX 15 mg/week results in a minor improvement in disease control. For patients with active RA receiving 15

show abstract

Section: Methodsmentioning

confidence: 99%

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial

Lambert¹,

Sandhu²,

Lochhead³

et al. 2004

Arthritis & Rheumatism

View full text Add to dashboard Cite

show abstract

“…We chose the SRM, as it is one of the most commonly used indices of responsiveness and takes the variation of change into account. [23][24][25][26] The SRM is calculated by dividing the mean change in scores by the standard deviation of the change. It can be easily interpreted by Cohen's interpretation of effect sizes with SRMs of at least 0.2 being regarded as small, SRMs of at least 0.5 as moderate, and SRMs of 0.8 or greater as large.…”

Section: Sf-36 and Sf-12 Questionnairesmentioning

confidence: 99%

Comparison of the Short Form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease

Müller‐Nordhorn

Roll

Willich

2003

Annals of Epidemiology

View full text Add to dashboard Cite

“…A summary score was obtained by taking the unweighted mean of the responses. The MHAQ is widely used to measure physical limitations due to rheumatic diseases and has acceptable reliability and validity (25)(26)(27).…”

mentioning

confidence: 99%

Use of the trust in physician scale in patients with rheumatic disease: Psychometric properties and correlates of trust in the rheumatologist

Freburger

Callahan

Currey

et al. 2003

Arthritis & Rheumatism

102

111

View full text Add to dashboard Cite

Objectives. To assess the psychometric properties of the Trust in Physician Scale and to identify variables associated with patients' trust in their rheumatologist. Methods. Analyses of self reported data from 713 patients with rheumatoid arthritis, osteoarthritis, or fibromyalgia. Study variables included the Trust in Physician Scale, a decision-making question, a medical skepticism measure, and demographic and health-related measures. Internal consistency and construct validity were assessed using correlational analyses and factor analysis. A regression analysis was conducted to identify factors associated with trust in the rheumatologist. Results. Internal consistency of the scale was high (Cronbach's alpha ‫؍‬ 0.87). Scale items also loaded on a single factor. Construct validity was supported by inverse correlations between higher trust scores and both skepticism and independent decision making. Decreased trust was associated with older age, minority status, higher education, diagnosis of fibromyalgia or osteoarthritis, and poorer health. Conclusion. The Trust in Physician Scale is appropriate for patients with rheumatic disease. Several patient characteristics appear to be associated with lower trust in the rheumatologist.

show abstract

Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis

Abstract: The SF12 is a reliable, valid and responsive measure of health status in the majority of RA patients, and meets standards required for comparing groups of patients. Its application in the most severely disabled subjects is uncertain.

Cited by 186 publications

References 3 publications

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial

Comparison of the Short Form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease

Use of the trust in physician scale in patients with rheumatic disease: Psychometric properties and correlates of trust in the rheumatologist

Contact Info

Product

Resources

About